- Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
- Mydecine Provides Q4 2023 Business Update
- Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK
- Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings
- Mydecine Announces Conditional Approval of CSE Listing
More ▼
Key statistics
On Wednesday, Mydecine Innovations Group Inc (MYCOF:PKC) closed at 0.0109, 10,800.00% above the 52 week low of 0.0001 set on Apr 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0061 |
---|---|
High | 0.0109 |
Low | 0.0061 |
Bid | -- |
Offer | -- |
Previous close | 0.0062 |
Average volume | 19.87k |
---|---|
Shares outstanding | 61.76m |
Free float | 61.16m |
P/E (TTM) | -- |
Market cap | 926.33k CAD |
EPS (TTM) | -1.06 CAD |
Data delayed at least 15 minutes, as of May 22 2024 20:53 BST.
More ▼